相关实验视频
Updated: Jan 31, 2026

06:47
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
Published on: January 28, 2021
12.4K
脂蛋白测试的趋势和对临床护理的影响:当代全系统分析
Mahima Mangla1, Tia Bimal2, Ehimare Akhabue3,4
1Northwell, Department of Internal Medicine, Lenox Hill Hospital, New York, NY USA.
American journal of preventive cardiology
|January 30, 2026
概括
脂蛋白 (Lp) 测试显著增加,显示了许多患者的高风险水平. 升高的Lp (a) 水平与更激进的降脂疗法有关,突出了提高认识和测试管理心血管疾病风险的必要性.
科学领域:
- 心脏病学 心脏病学
- 临床脂质学 临床脂质学
- 预防医学 预防医学
背景情况:
- 升高的脂蛋白 (Lp) 是一种已知的动脉样硬化心血管疾病 (ASCVD) 的因果风险因素.
- 尽管具有重要意义,但在医疗保健系统中,Lp (a) 测试率在历史上一直很低.
- 提高认识和测试努力的目的是改善与Lp (a) 相关的心血管风险的管理.
研究的目的:
- 评估随着时间的推移,Lp(a) 测试率的趋势.
- 评估Lp (a) 测试对临床护理的影响,包括降脂疗法 (LLT) 处方和心脏病转诊.
- 确定不同Lp (a) 风险类别的患病率及其与治疗强度的关联.
主要方法:
- 利用电子健康记录查询Lp (a) 测试率从2022年1月1日到2024年12月31日.
- 收集了关于患者人口统计,ASCVD状态,测试专业,LLT处方和心脏病转诊的数据.
- 分析了Lp(a) 级别和LLT启动/升级之间的关联.
主要成果:
- 在2022年至2024年期间,Lp (a) 测试从3052个增加到8425个订单,尽管整体测试仍然很低,为3.7% (16,476/450,412名患者).
- 在各种患者群体中,高风险的Lp(a) 水平 (≥75nmol/L) 普遍存在,包括那些没有确定的ASCVD患者.
- 较高的Lp(a) 水平与LLT启动或升级率的增加正相关 (p < 0.0001).
结论:
- 测试率虽然最初很低,但在研究期间显示出大幅增长.
- 经常发现高Lp (a) 水平,表明有显著的心血管风险,并且与更密集的治疗策略相关.
- 加强Lp (a) 意识和测试的系统举措对于有效减轻心血管风险至关重要.
相关概念视频
Contemporary Psychology
2.2K
Psychology explores human behavior and mental processes through various lenses, each offering unique insights. This overview examines key subfields, including biopsychology, evolutionary, developmental, personality, and social psychology, highlighting their approaches and contributions to understanding complex human behaviors.
Biopsychology
Biopsychology, also known as biological psychology or behavioral neuroscience, focuses on the biological underpinnings of behavior and mental processes. It...
Biopsychology
Biopsychology, also known as biological psychology or behavioral neuroscience, focuses on the biological underpinnings of behavior and mental processes. It...
2.2K
Myocarditis II: Clinical Features and Diagnostic Tests
318
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
318
Pericarditis II: Clinical Features and Diagnostic Tests
324
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
324
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
530
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
530
Mitral Stenosis II: Clinical features and Diagnostic Tests
262
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
262
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
512
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
512

